Letter submitted to Congressional Leadership
Brenda Knapp2019-03-29T16:35:04-04:00KidneyCan submitted a letter to the Congressional leadership of the House Appropriations Committee in early March. The letter was hand delivered
First In Human: So Far, So Good
Brenda Knapp2019-03-29T18:40:19-04:00My husband Ralph is in his 4th day of a First In Human clinical trial at NIH. He is patient #3.
First in Human: Infusion Day
Brenda Knapp2019-03-26T18:42:02-04:00Day zero: Super T-cell infusion day! Ralph received his new T-cells on 3/25 at 11:54 am. What an exciting day for
First in Human: Waiting for the Super T-Cells
Brenda Knapp2019-04-02T10:52:00-04:00My husband is participating in a clinical trial at NIH. It's a Phase 1, First in Human trial for kidney cancer.
First In Human Clinical Trial
Brenda Knapp2019-03-28T18:08:03-04:00My husband has a chance for a cure. He is patient #3 in a first in human clinical trial for kidney
Kidney Cancer Advocacy Day – March 12, 2019
Bryan Lewis2019-03-28T18:05:51-04:00KidneyCAN sponsored the Kidney Cancer Advocacy Day in DC and was attended by more than 20 kidney cancer patient advocates from
A Common Bond
Brenda Knapp2019-03-28T18:07:25-04:00What do these men have in common? Their common bond is a potentially life saving kidney cancer
UT Southwestern – Cutting-edge Discoveries, Transforming Patient Care
Brenda Knapp2019-03-23T12:30:26-04:00UT Southwestern - Cutting-edge Discoveries, Transforming Patient Care The American Cancer Society estimates that in 2014, 63,920 people were diagnosed with kidney